Login
$IRWD
$4.76 -$0.09 (1.85%) After hours

$IRWD 8-K/A SEC Filings

Filed On Filing
21 May 2026 8-K/A: Departure/Election of Directors or Officers; Compensation

On May 19, 2026, in connection with Mr. Silver’s new role as the Company’s interim chief financial officer and principal financial officer, the Committee approved a monthly interim assignment fee of $12,250 (the “Interim CFO Assignment F...

11 Sep 2023 8-K/A: Financial Statements and Exhibits

To the Shareholders and the Board of Directors of VectivBio Holding AG

24 Jun 2021 8-K/A: Departure/Election of Directors or Officers; Compensation

This Second Amended & Restated Executive Severance Agreement (this “Agreement”) is made as of the day of June 22, 2021 (the “Effective Date”) by and between Ironwood Pharmaceuticals, Inc., a Delaware corporation (the “Company”), and Thom...

15 Mar 2021 8-K/A: Departure/Election of Directors or Officers; Compensation

In connection with Mr. McCourt becoming the Company’s interim Chief Executive Officer, the Board approved an annual base salary of $775,000 (the “Interim CEO Salary”) and target bonus of 75% of the Interim CEO Salary for Mr. McCourt. Mr....

03 May 2019 8-K/A: Departure/Election of Directors or Officers; Compensation

As previously reported, on April 1, 2019, the Company completed the separation of its soluble guanylate cyclase business, and certain other assets and liabilities, into a separate, independent publicly traded company. This separation was...

28 Mar 2019 8-K/A: Departure/Election of Directors or Officers; Compensation

The completion of the Separation is currently expected to occur on April 1, 2019 (the “Separation Date”). At that time, the New Ironwood Directors (as defined in the January 24 Report) are expected to be appointed to the Board and the De...

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support